Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Byrne: health "moving to the EU political centre":

This article was originally published in Clinica

Executive Summary

Healthcare issues are being accorded an increasingly high profile in the EU, David Byrne, the EU Commissioner for Health and Consumer Protection, noted during his keynote speech at the launch event for the European Centre For Disease Prevention and Control (ECDC). "The last five years have seen the political profile of health policy steadily increase. Health has steadily moved from the margins to the centre of the EU's political agenda," he said, addressing senior health officials and politicians from around Europe, North America and Asia. The ECDC, which will among other things act as an EU epidemiological surveillance point and round-the-clock early warning and response system with the availability of specialists in communicable diseases, is due to start work in May next year. See also Clinica No 1125, p 9.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059710

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel